From: Down-regulated miR-495 can target programmed cell death 10 in ankylosing spondylitis
Characteristics | AS (N = 150) | HC (N = 150) |
---|---|---|
Gender (Male/Female) | Male (N = 114) Female (N = 36) | Male (N = 114) Female (N = 36) |
Age (years) | M: 34.0 ± 12.5 F: 32.5 ± 10.5 | M: 35.5 ± 10.5 F: 33.5 ± 8.5 |
Disease duration (years), mean ± SD | 5.5 ± 0.8 | 0 |
HLA-B27, mean ± SD (0~147) | 161.0 ± 8.5 | Normal |
ESR (mm/h), mean ± SD (0~15 for Male; 0~20 for Female) | 22.5 ± 11.9 | Normal |
CRP (mg/dL), mean ± SD (1~15) | 0.82 ± 0.54 | Normal |
BASDAI, mean ± SD | 4.43 ± 1.35 | Normal |
BASFI, mean ± SD | 36.8 ± 19.6 | Normal |
mSASSS | 13.0 ± 7.0 | Normal |
Suggestions for immunosuppressant drugs | ||
 Steroids | 4% | 0 |
 DMARDs | 6% | 0 |
 NSAIDs | 100% | 0 |